Israeli AI Mental Health Tech Expands to Global Market

An Israeli company, Taliaz, has developed an AI-based system designed to streamline the work of psychiatrists and improve mental healthcare accessibility. The technology aims to reduce waiting times for psychiatric treatment, a growing concern exacerbated by increased rates of post-traumatic stress and overall strain on mental health services.

The AI system assists psychiatrists by providing them with patient background information before appointments, enabling data-driven treatment decisions and personalized care. It does not replace medical judgment but rather optimizes psychiatrists' workflows by reducing time spent on intake, documentation, and administrative tasks. This efficiency allows healthcare teams to dedicate more time to patient treatment and serve a larger number of individuals.

Taliaz has recently launched operations in England as part of its global expansion strategy, addressing common challenges faced by mental health systems worldwide. Concurrently, the company is collaborating with Israeli health maintenance organizations (HMOs) to make its services subsidized and widely accessible within Israel.

Dr. Dekel Taliaz, founder of Taliaz and a neuroscientist, emphasized the importance of timely professional help for individuals in psychological distress. He stated that the developed technology enhances psychiatrist efficiency, supports better treatment decisions, and ensures each patient receives tailored care with full transparency. The company's objective is to facilitate access to appropriate help for as many people as possible when they need it most.